What is the primary purpose of this 10-Q filing?

This Form 10-Q is a quarterly report filed by HCA Inc. with the SEC to provide investors with unaudited financial information and updates on the company's operations, financial condition, and material events for the fiscal quarter ended June 30, 2005.

What does it mean that HCA is an 'accelerated filer'?

Being an accelerated filer means HCA meets certain criteria set by the SEC, typically related to its public float (the market value of its shares held by non-affiliates). Accelerated filers are generally required to file their annual and quarterly reports more promptly than non-accelerated filers.

Where can I find details about HCA's financial performance in Q2 2005?

Detailed financial performance metrics such as revenue, expenses, and net income for Q2 2005 can be found in the 'Condensed Consolidated Income Statements' and the 'Management’s Discussion and Analysis of Financial Condition and Results of Operations' sections within the full 10-Q report.

Are there any significant risks or legal issues mentioned in this filing excerpt?

The table of contents indicates a section on 'Legal Proceedings'. Investors should review this section carefully in the complete filing for information on any ongoing lawsuits or regulatory actions that could potentially impact HCA's financial results or operations.

HCA 10-Q Quarterly Report Q2 FY2005 — Revenue, Net Income, EPS

Summary

HCA Healthcare, Inc.'s (HCA) second-quarter 2005 report for the period ending June 30, 2005, indicates continued operational activity. The company is reporting its financial results as an accelerated filer. While specific financial figures like revenue, net income, and debt levels for the quarter are not detailed in this excerpt, investors should note the company's filing status and the standard sections presented in the 10-Q, which include condensed consolidated financial statements and Management's Discussion and Analysis of Financial Condition and Results of Operations. Investors interested in HCA should pay close attention to the detailed financial statements and the MD&A section for a comprehensive understanding of the company's performance, liquidity, and any significant changes or risks. The report also lists legal proceedings, which could have a material impact on the company's financial health and future operations.

Key Highlights

1HCA Inc. filed its Quarterly Report (10-Q) for the period ended June 30, 2005.
2The company is classified as an accelerated filer, suggesting a significant market capitalization and history of timely SEC filings.
3The filing includes unaudited Condensed Consolidated Income Statements, Balance Sheets, and Cash Flows for the relevant periods.
4Management's Discussion and Analysis (MD&A) is provided, offering insights into the company's financial condition and operational results.
5The report details the number of outstanding shares of common stock as of June 30, 2005: 430,962,600 shares of voting common stock and 21,000,000 shares of nonvoting common stock.
6Information regarding Legal Proceedings is disclosed, which is a critical area for investors to assess potential liabilities.
7The report confirms the company is subject to the filing requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934.

HCA Healthcare, Inc. Quarterly Report for Q2 Ended Jun 30, 2005

Summary

Key Highlights

Frequently Asked Questions